VRDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Viridian Therapeutics, Inc.\DE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$20.80+1.77 (+9.30%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Viridian Therapeutics, Inc.\DE's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2026 | Jun 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | May 27, 2026 | May 28, 2026 | SEC EDGAR |
| Current report | 8-K | May 24, 2026 | May 26, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 2, 2026 | Apr 17, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 21, 2025 | Oct 23, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 21, 2025 | Oct 21, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 17, 2025 | Oct 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 24, 2025 | SEC EDGAR |
| Current report | 8-K | May 20, 2025 | May 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 20, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 2, 2025 | Apr 7, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2025 | Mar 10, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 4, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2025 | Jan 10, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2024 | Dec 16, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2024 | Sep 12, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2024 | Sep 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |